About Aclaris (ACRS)
Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a physician-led, biopharmaceutical company focused on immuno-inflammatory diseases. The Company is focused on leveraging its experience in drug discovery and development and kinase inhibit... Read more
- USD3.97
- USD4.03
- USD3.77
- USD5.17
- 74.30%
- 27M
- 1.07M
- 6.03M
- 291M
- 0.80
- 286.30%
Stock News
yesterday
Jim Cramer reviews companies that cracked $100 billion in 2024
CNBC
yesterday
Comcast seen taking ‘one step forward, two steps back’ in tough broadband market
MarketWatch
yesterday
Oracle shares slide on earnings and revenue miss
CNBC
yesterday
From 'Fortnite' to 'Hogwarts Legacy': One university fuels Utah's $2 billion video game industry
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
